S&P 500   4,976.10 (-0.70%)
DOW   37,897.35 (+0.32%)
QQQ   415.42 (-1.89%)
AAPL   164.27 (-1.66%)
MSFT   398.62 (-1.40%)
META   480.39 (-4.27%)
GOOGL   152.67 (-2.14%)
AMZN   174.37 (-2.71%)
TSLA   148.39 (-1.03%)
NVDA   807.91 (-4.58%)
AMD   148.64 (-4.15%)
NIO   3.81 (-4.75%)
BABA   68.49 (-0.57%)
T   16.30 (-0.18%)
F   12.06 (+0.00%)
MU   106.85 (-4.54%)
GE   146.98 (-3.90%)
CGC   7.93 (+1.28%)
DIS   111.72 (-0.63%)
AMC   3.18 (+8.90%)
PFE   25.74 (+1.38%)
PYPL   61.87 (-0.37%)
XOM   119.71 (+1.00%)
S&P 500   4,976.10 (-0.70%)
DOW   37,897.35 (+0.32%)
QQQ   415.42 (-1.89%)
AAPL   164.27 (-1.66%)
MSFT   398.62 (-1.40%)
META   480.39 (-4.27%)
GOOGL   152.67 (-2.14%)
AMZN   174.37 (-2.71%)
TSLA   148.39 (-1.03%)
NVDA   807.91 (-4.58%)
AMD   148.64 (-4.15%)
NIO   3.81 (-4.75%)
BABA   68.49 (-0.57%)
T   16.30 (-0.18%)
F   12.06 (+0.00%)
MU   106.85 (-4.54%)
GE   146.98 (-3.90%)
CGC   7.93 (+1.28%)
DIS   111.72 (-0.63%)
AMC   3.18 (+8.90%)
PFE   25.74 (+1.38%)
PYPL   61.87 (-0.37%)
XOM   119.71 (+1.00%)
S&P 500   4,976.10 (-0.70%)
DOW   37,897.35 (+0.32%)
QQQ   415.42 (-1.89%)
AAPL   164.27 (-1.66%)
MSFT   398.62 (-1.40%)
META   480.39 (-4.27%)
GOOGL   152.67 (-2.14%)
AMZN   174.37 (-2.71%)
TSLA   148.39 (-1.03%)
NVDA   807.91 (-4.58%)
AMD   148.64 (-4.15%)
NIO   3.81 (-4.75%)
BABA   68.49 (-0.57%)
T   16.30 (-0.18%)
F   12.06 (+0.00%)
MU   106.85 (-4.54%)
GE   146.98 (-3.90%)
CGC   7.93 (+1.28%)
DIS   111.72 (-0.63%)
AMC   3.18 (+8.90%)
PFE   25.74 (+1.38%)
PYPL   61.87 (-0.37%)
XOM   119.71 (+1.00%)
S&P 500   4,976.10 (-0.70%)
DOW   37,897.35 (+0.32%)
QQQ   415.42 (-1.89%)
AAPL   164.27 (-1.66%)
MSFT   398.62 (-1.40%)
META   480.39 (-4.27%)
GOOGL   152.67 (-2.14%)
AMZN   174.37 (-2.71%)
TSLA   148.39 (-1.03%)
NVDA   807.91 (-4.58%)
AMD   148.64 (-4.15%)
NIO   3.81 (-4.75%)
BABA   68.49 (-0.57%)
T   16.30 (-0.18%)
F   12.06 (+0.00%)
MU   106.85 (-4.54%)
GE   146.98 (-3.90%)
CGC   7.93 (+1.28%)
DIS   111.72 (-0.63%)
AMC   3.18 (+8.90%)
PFE   25.74 (+1.38%)
PYPL   61.87 (-0.37%)
XOM   119.71 (+1.00%)

Pacira BioSciences (PCRX) SEC Filings & 10K Form

$26.02
-0.08 (-0.31%)
(As of 12:39 PM ET)

Recent Pacira BioSciences SEC Filings

DateFilerForm TypeView
03/08/2024
4:33 PM
PACE GARY W (Reporting)
Pacira BioSciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/29/2024
4:29 PM
Pacira BioSciences (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
02/29/2024
2:33 PM
Pacira BioSciences (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
02/29/2024
7:03 AM
Pacira BioSciences (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/19/2024
1:40 PM
BlackRock Inc. (Filed by)
Pacira BioSciences (Subject)
Form SC 13G/A
01/04/2024
4:21 PM
Lee Frank D. (Reporting)
Pacira BioSciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/04/2024
4:24 PM
Pacira BioSciences (Issuer)
SLONIN JONATHAN (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/04/2024
4:25 PM
Pacira BioSciences (Issuer)
RIKER LAUREN (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/04/2024
4:18 PM
Lee Frank D. (Reporting)
Pacira BioSciences (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
12/21/2023
6:33 AM
Pacira BioSciences (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/07/2023
6:44 PM
Pacira BioSciences (Issuer)
SLONIN JONATHAN (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
11/13/2023
8:41 AM
Pacira BioSciences (Subject)
WINSTON ROY (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
11/02/2023
1:59 PM
Pacira BioSciences (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
11/02/2023
7:01 AM
Pacira BioSciences (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/11/2023
3:42 PM
BIGAL MARCELO (Reporting)
Pacira BioSciences (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
10/11/2023
3:42 PM
Ceesay Abraham (Reporting)
Pacira BioSciences (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
10/11/2023
3:43 PM
Pacira BioSciences (Issuer)
YANG MICHAEL J. (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
10/11/2023
3:43 PM
Pacira BioSciences (Issuer)
Young Alethia (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
10/11/2023
3:46 PM
Ceesay Abraham (Reporting)
Pacira BioSciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
10/11/2023
3:46 PM
BIGAL MARCELO (Reporting)
Pacira BioSciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
10/11/2023
3:46 PM
Pacira BioSciences (Issuer)
YANG MICHAEL J. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/11/2023
3:47 PM
Pacira BioSciences (Issuer)
Young Alethia (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/10/2023
7:02 AM
Pacira BioSciences (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/26/2023
3:32 PM
Pacira BioSciences (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/02/2023
7:02 AM
Pacira BioSciences (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/07/2023
7:04 PM
Pacira BioSciences (Issuer)
Riker Lauren Bullaro (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/05/2023
11:25 AM
Pacira BioSciences (Subject)
Riker Lauren Bullaro (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
06/16/2023
4:45 PM
Pacira BioSciences (Issuer)
WINSTON ROY (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/16/2023
4:31 PM
GAUGLER DARYL (Reporting)
Pacira BioSciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/16/2023
4:32 PM
HASTINGS PAUL J (Reporting)
Pacira BioSciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/16/2023
4:34 PM
Kronenfeld Mark A. (Reporting)
Pacira BioSciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/16/2023
4:36 PM
PACE GARY W (Reporting)
Pacira BioSciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/16/2023
4:38 PM
Pacira BioSciences (Issuer)
Reinhart Charles A. III (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/16/2023
4:39 PM
Pacira BioSciences (Issuer)
Riker Lauren Bullaro (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/16/2023
4:40 PM
Pacira BioSciences (Issuer)
STACK DAVID M (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/16/2023
4:42 PM
Pacira BioSciences (Issuer)
Williams Kristen Marie (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/16/2023
4:26 PM
Brege Laura (Reporting)
Pacira BioSciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/16/2023
4:28 PM
CHRISTIE CHRISTOPHER (Reporting)
Pacira BioSciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/16/2023
4:30 PM
Froimson Mark (Reporting)
Pacira BioSciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/14/2023
3:40 PM
Pacira BioSciences (Subject)
Riker Lauren Bullaro (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
06/14/2023
1:48 PM
Pacira BioSciences (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
With the “Bitcoin Loophole” you can supercharge the gains by 10x or more (Ad)

Thanks to this newly discovered Bitcoin Loophole, you can now trade Bitcoin in any regular brokerage account… And not only that… you can use it to supercharge the gains of Bitcoin by 10x or more! You see, thanks to one unique investor's brand new discovery - anyone with a regular brokerage account can now tap into the most explosive asset in history. That means you can skip the hassle of opening a Coinbase account… Bypass the fees and hard-to-remember passwords…

Sign up here for a FREE workshop to discover one trader’s $213,000 real-money trade! 
06/14/2023
1:48 PM
Pacira BioSciences (Subject)
Williams Kristen Marie (Reporting)
Williams Kristen Marie (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
06/12/2023
3:16 PM
Kronenfeld Mark A. (Reporting)
Pacira BioSciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/12/2023
10:08 AM
Pacira BioSciences (Subject)
REINHARDT MAX (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
06/08/2023
9:40 AM
Kronenfeld Mark A. (Reporting)
Pacira BioSciences (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
06/07/2023
8:22 PM
GAUGLER DARYL (Reporting)
Pacira BioSciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/07/2023
8:23 PM
HASTINGS PAUL J (Reporting)
Pacira BioSciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/07/2023
8:24 PM
McLoughlin Dennis (Reporting)
Pacira BioSciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/07/2023
8:26 PM
MOLLOY ANTHONY (Reporting)
Pacira BioSciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/07/2023
8:28 PM
Pacira BioSciences (Issuer)
REINHARDT MAX (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/07/2023
8:29 PM
Pacira BioSciences (Issuer)
Reinhart Charles A. III (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/07/2023
8:31 PM
Pacira BioSciences (Issuer)
Riker Lauren Bullaro (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/07/2023
8:32 PM
Pacira BioSciences (Issuer)
SLONIN JONATHAN (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/07/2023
8:33 PM
Pacira BioSciences (Issuer)
STACK DAVID M (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/07/2023
8:34 PM
Pacira BioSciences (Issuer)
Williams Kristen Marie (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/07/2023
8:36 PM
Pacira BioSciences (Issuer)
WINSTON ROY (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/07/2023
8:18 PM
Brege Laura (Reporting)
Pacira BioSciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/07/2023
8:20 PM
Ellis Ronald J. Jr. (Reporting)
Pacira BioSciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/07/2023
4:37 PM
McLoughlin Dennis (Reporting)
Pacira BioSciences (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
06/07/2023
4:45 PM
Pacira BioSciences (Subject)
Reinhart Charles A. III (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
06/07/2023
4:45 PM
Pacira BioSciences (Subject)
SLONIN JONATHAN (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
06/07/2023
4:47 PM
Pacira BioSciences (Subject)
Riker Lauren Bullaro (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
06/07/2023
4:59 PM
GAUGLER DARYL (Reporting)
Pacira BioSciences (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
06/07/2023
4:28 PM
Pacira BioSciences (Subject)
STACK DAVID M (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
06/07/2023
4:30 PM
Ellis Ronald J. Jr. (Reporting)
Pacira BioSciences (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
06/07/2023
3:53 PM
Pacira BioSciences (Subject)
WINSTON ROY (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
06/07/2023
4:00 PM
Pacira BioSciences (Subject)
REINHARDT MAX (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
06/07/2023
4:08 PM
Pacira BioSciences (Subject)
Williams Kristen Marie (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
06/06/2023
4:13 PM
GAUGLER DARYL (Reporting)
Pacira BioSciences (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
06/06/2023
4:14 PM
Pacira BioSciences (Subject)
REINHARDT MAX (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
06/06/2023
4:23 PM
Pacira BioSciences (Subject)
SLONIN JONATHAN (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
06/06/2023
3:53 PM
Pacira BioSciences (Subject)
STACK DAVID M (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
06/06/2023
3:58 PM
McLoughlin Dennis (Reporting)
Pacira BioSciences (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
06/06/2023
3:39 PM
Ellis Ronald J. Jr. (Reporting)
Pacira BioSciences (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
06/06/2023
3:44 PM
Pacira BioSciences (Subject)
Riker Lauren Bullaro (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
06/06/2023
3:29 PM
Pacira BioSciences (Subject)
Williams Kristen Marie (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
06/06/2023
3:32 PM
Pacira BioSciences (Subject)
WINSTON ROY (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
06/06/2023
3:34 PM
Pacira BioSciences (Subject)
Reinhart Charles A. III (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
06/06/2023
12:32 PM
MOLLOY ANTHONY (Reporting)
Pacira BioSciences (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
06/05/2023
2:49 PM
MOLLOY ANTHONY (Reporting)
Pacira BioSciences (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
06/05/2023
1:03 PM
HASTINGS PAUL J (Reporting)
Pacira BioSciences (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
06/05/2023
9:51 AM
GAUGLER DARYL (Reporting)
Pacira BioSciences (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
06/05/2023
9:09 AM
Brege Laura (Reporting)
Pacira BioSciences (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
06/02/2023
5:28 PM
GAUGLER DARYL (Reporting)
Pacira BioSciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/31/2023
9:32 AM
GAUGLER DARYL (Reporting)
Pacira BioSciences (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
05/15/2023
5:53 PM
PACE GARY W (Reporting)
Pacira BioSciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/15/2023
9:30 AM
HASTINGS PAUL J (Reporting)
Pacira BioSciences (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
05/11/2023
1:01 PM
PACE GARY W (Reporting)
Pacira BioSciences (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
05/03/2023
2:37 PM
Pacira BioSciences (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
05/03/2023
7:02 AM
Pacira BioSciences (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
(Data available from 1/1/2016 forward)


Related Companies and Tools

This page (NASDAQ:PCRX) was last updated on 4/19/2024 by MarketBeat.com Staff

From Our Partners